Suppr超能文献

老年小鼠中源自B-1的抗Thy-1 B细胞会发展为淋巴瘤/白血病,其CD11b和Hamp2表达较高,这与TCL1转基因小鼠不同。

B-1 derived anti-Thy-1 B cells in old aged mice develop lymphoma/leukemia with high expression of CD11b and Hamp2 that different from TCL1 transgenic mice.

作者信息

Hayakawa Kyoko, Zhou Yan, Shinton Susan A

机构信息

Fox Chase Cancer Center, 333 Cottman Ave., Philadelphia, PA, 19111, USA.

出版信息

Immun Ageing. 2024 Apr 3;21(1):22. doi: 10.1186/s12979-024-00415-6.

Abstract

Human old aged unmutated chronic lymphocytic leukemia U-CLL are the TCL1ZAP70CD5 B cells. Since CD5 makes the BCR signaling tolerance, ZAP70 increased in U-CLL not only TCL1 alone. In mice, TCL1 (TCL1A) is the negative from neonate to old aged, as TC. V8-12/V21-5 is the anti-thymocyte/Thy-1 autoreactive ATA B cell. When ATA μκTg generation in mice, ATA B cells are the neonate generated CD5 B cells in B-1, and in the middle age, CD5 can be down or continuously CD5, then, old aged CLL/lymphoma generation with increased CD11b in TCZAP70CD5 or TCZAP70CD5. In this old aged TCATA B microarray analysis showed most similar to human CLL and U-CLL, and TCZAP70CD5 showed certain higher present as U-CLL. Original neonate ATA B cells showed with several genes down or further increase in old aged tumor, and old aged T-betCD11c, CTNNB1, HMGB, CXCR4, DPP4 and decreased miR181b. These old aged increased genes and down miR181b are similar to human CLL. Also, in old age ATA B cell tumor, high CD38CD44, increased Ki67 AID, and decreased CD180 miR15O are similar to U-CLL. In this old aged ATA B, increased TLR7,9 and Wnt10b. TCTg generated with ATAμκTg mice occurred middle age tumor as TCZAP70CD5 or TCZAP70CD5, with high NF-kB1, TLR4,6 and Wnt5b,6 without increased CD11b. Since neonatal state to age with TCTg continuously, middle age CLL/lymphoma generation is not similar to old aged generated, however, some increased in TCZAP70 are similar to the old age TC ATA B tumor. Then, TC ATA B old age tumor showed some difference to human CLL. ATA B cells showed CD11bCD22, CD24 down, and hepcidin Hamp2 with iron down. This mouse V8-12 similar to human V2-5, and V2-5 showed several cancers with macrophages/neutrophils generated hepcidin iron or some showed hepcidin iron with tumor, and mouse V8-12 with different V19-17 generate MZ B cells strongly increased macrophage in old aged and generated intestine/colon tumor. Conclusion, neonate generated TCATA B1 cells in old aged tumor generation are CD11b in the leukemia CLL together with lymphoma cancer with hepcidin-related Hamp2 in B-1 cell generation to control iron.

摘要

人类老年未突变慢性淋巴细胞白血病U-CLL是TCL1、ZAP70、CD5的B细胞。由于CD5使BCR信号耐受,U-CLL中ZAP70增加不仅是由于单独的TCL1。在小鼠中,TCL1(TCL1A)从新生儿到老年都是阴性,作为TC。V8-12/V21-5是抗胸腺细胞/Thy-1自身反应性ATA B细胞。当在小鼠中产生ATA μκTg时,ATA B细胞是在B-1中产生的新生儿CD5 B细胞,在中年时,CD5可下调或持续表达CD5,然后,在TCZAP70CD5或TCZAP70CD5中随着CD11b增加而产生老年CLL/淋巴瘤。在这种老年TCATA B微阵列分析中显示与人类CLL和U-CLL最相似,并且TCZAP70CD5显示出作为U-CLL有一定更高的表达。原始新生儿ATA B细胞在老年肿瘤中显示出几个基因下调或进一步增加,以及老年T-bet、CD11c、CTNNB1、HMGB、CXCR4、DPP4增加和miR181b减少。这些老年增加的基因和下调的miR181b与人类CLL相似。此外,在老年ATA B细胞肿瘤中,高CD38、CD44、增加的Ki67、AID以及减少的CD180、miR15O与U-CLL相似。在这种老年ATA B中,TLR7、9和Wnt10b增加。用ATAμκTg小鼠产生的TCTg在中年时出现肿瘤,如TCZAP70CD5或TCZAP70CD5,具有高NF-kB1、TLR4、6和Wnt5b、6且CD11b不增加。由于从新生儿状态到老年TCTg持续存在,中年CLL/淋巴瘤的产生与老年产生的不同,然而,TCZAP70中的一些增加与老年TC ATA B肿瘤相似。然后,TC ATA B老年肿瘤与人类CLL表现出一些差异。ATA B细胞显示CD11b、CD22、CD24下调,以及铁调素Hamp2随着铁减少。这种小鼠V8-12与人类V2-5相似,并且V2-5在几种癌症中与巨噬细胞/中性粒细胞产生铁调素铁,或者一些显示肿瘤伴有铁调素铁,并且具有不同V19-17的小鼠V8-12在老年时强烈增加MZ B细胞并产生肠道/结肠肿瘤。结论,在老年肿瘤产生中新生儿产生的TCATA B1细胞在白血病CLL中是CD11b,连同淋巴瘤癌症,在B-1细胞产生中与铁调素相关的Hamp2一起控制铁。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0562/10988983/b12aaeba8604/12979_2024_415_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验